Analysts Offer Predictions for LHC Group, Inc.’s Q1 2018 Earnings (LHCG)

LHC Group, Inc. (NASDAQ:LHCG) – Research analysts at Jefferies Group issued their Q1 2018 earnings estimates for shares of LHC Group in a research report issued on Wednesday, April 4th. Jefferies Group analyst B. Tanquilut anticipates that the health services provider will earn $0.59 per share for the quarter. Jefferies Group has a “Buy” rating and a $84.00 price objective on the stock. Jefferies Group also issued estimates for LHC Group’s Q2 2018 earnings at $0.77 EPS, Q3 2018 earnings at $0.97 EPS, Q4 2018 earnings at $1.17 EPS and FY2018 earnings at $3.50 EPS.

How to Become a New Pot Stock Millionaire

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, February 28th. The health services provider reported $0.62 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.62. The company had revenue of $292.40 million for the quarter, compared to analysts’ expectations of $280.82 million. LHC Group had a net margin of 4.67% and a return on equity of 9.18%. LHC Group’s quarterly revenue was up 24.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.58 EPS.

LHCG has been the topic of a number of other reports. BidaskClub raised shares of LHC Group from a “sell” rating to a “hold” rating in a report on Wednesday. Zacks Investment Research raised shares of LHC Group from a “sell” rating to a “hold” rating in a report on Wednesday, January 31st. Oppenheimer reaffirmed a “buy” rating and issued a $85.00 target price on shares of LHC Group in a report on Thursday, December 7th. Stephens set a $74.00 target price on shares of LHC Group and gave the company a “buy” rating in a report on Friday, March 2nd. Finally, Craig Hallum upped their target price on shares of LHC Group from $70.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday. Three research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $76.80.

Shares of LHCG stock opened at $70.66 on Friday. The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $1,271.00, a PE ratio of 29.20, a PEG ratio of 1.12 and a beta of 0.70. LHC Group has a 52-week low of $51.38 and a 52-week high of $76.14.

Institutional investors have recently added to or reduced their stakes in the business. LS Investment Advisors LLC raised its holdings in LHC Group by 249.5% in the 4th quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock valued at $152,000 after acquiring an additional 1,769 shares during the period. SG Americas Securities LLC bought a new position in LHC Group in the 3rd quarter valued at about $163,000. Jefferies Group LLC bought a new position in LHC Group in the 4th quarter valued at about $200,000. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp bought a new position in LHC Group in the 4th quarter valued at about $251,000. Finally, Crossmark Global Holdings Inc. raised its holdings in LHC Group by 28.0% in the 4th quarter. Crossmark Global Holdings Inc. now owns 5,036 shares of the health services provider’s stock valued at $308,000 after acquiring an additional 1,103 shares during the period. 89.87% of the stock is currently owned by hedge funds and other institutional investors.

In other LHC Group news, COO Donald Dwayne Stelly sold 14,216 shares of the stock in a transaction dated Tuesday, March 13th. The shares were sold at an average price of $64.00, for a total value of $909,824.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 14.80% of the stock is owned by corporate insiders.

WARNING: “Analysts Offer Predictions for LHC Group, Inc.’s Q1 2018 Earnings (LHCG)” was published by Ticker Report and is the property of of Ticker Report. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3334383/analysts-offer-predictions-for-lhc-group-inc-s-q1-2018-earnings-lhcg.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Earnings History and Estimates for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Capital One Financial Weighs in on Cousins Properties’ Q3 2018 Earnings
Capital One Financial Weighs in on Cousins Properties’ Q3 2018 Earnings
Royal Gold  Forecasted to Post Q3 2018 Earnings of $0.42 Per Share
Royal Gold Forecasted to Post Q3 2018 Earnings of $0.42 Per Share
Campbell Soup  Forecasted to Post Q3 2018 Earnings of $0.60 Per Share
Campbell Soup Forecasted to Post Q3 2018 Earnings of $0.60 Per Share
Infineon Technologies  PT Set at €28.00 by Goldman Sachs
Infineon Technologies PT Set at €28.00 by Goldman Sachs
Hauck & Aufhaeuser Reiterates €16.50 Price Target for Hamburger Hafen und Logistik
Hauck & Aufhaeuser Reiterates €16.50 Price Target for Hamburger Hafen und Logistik
Drägerwerk  Earns “Neutral” Rating from Deutsche Bank
Drägerwerk Earns “Neutral” Rating from Deutsche Bank


Leave a Reply

© 2006-2018 Ticker Report. Google+.